HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas

Clinical trial NCT00874861 · COMPLETED

Trial details

NCT number: NCT00874861
Sponsor: Ian F. Pollack, M.D.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Astrocytoma Oligoastrocytoma Oligodendroglioma

Start date: 2009-04-01
Primary completion: 2012-05-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.